
Signs of growth are looking positive for both the EdTech business of CL Educate, while the MarTech business focused on internationalization and improvement of margins. MBA entrance exam numbers moved up after several years of stagnation, raising prospects of better growth for CL Educate’s flagship business: CAT entrance tests. H2…
Read More
CL Educate revenues were up about 30% in Q1 FY’24, with strong growth in both EdTech and MarTech business. The management has been saying it is focused on delivering strong growth henceforth, the Q1 results show it is walking the talk. Drilling down, EdTech and MarTech registered 33% and 23%…
Read More
Indrayani Biotech Limited (IBL) clocked a strong growth trajectory in FY23 with consolidated revenues of Rs 167 crore, as compared to revenue of Rs 62 crore in FY22. FY23 turned out to be a transformational year, with revenue growth of 171%. EBITDA margins also showed an upward trend. Indrayani reported…
Read More
The initial reaction of the market to the Q4 and full year FY23 results of CL Educate (NSE: CLEDUCATE, BSE: 540403) was negative. The stock fell 2% on 11-May-23 to close at Rs 53.15, the Thursday of the last week, the day the results were declared. However, the next day,…
Read More
For more than a month now, the share price of CL Educate (BSE: 540403, NSE: CLEDUCATE), has traded around Rs 55 levels, somewhat insulated against the global market turmoil. At this levels, the stock is down 15% on a y-o-y basis. CL Educate stock was last seen at these levels…
Read More
Growth momentum continued in Q3 FY23 despite Q3 traditionally being the weakest quarter due to exams. EdTech and MarTech revenues were up 31% and 22% respectively on a y-o-y basis. CL has crossed FY22 revenue and EBITDA in 9m FY23. While much of this recovery is due to return to…
Read More